JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 877.82 Million CNY | -12.78% |
| 2022 | 755.07 Million CNY | -3.22% |
| 2021 | 780.2 Million CNY | 66.55% |
| 2020 | 468.45 Million CNY | 130.18% |
| 2019 | 203.51 Million CNY | 73.9% |
| 2018 | 117.03 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 20.03 Million USD | 0.0% |
| 2024 Q1 | 20.16 Million USD | -46.7% |
| 2023 Q4 | 37.84 Million USD | 24.71% |
| 2023 FY | 658.61 Million CNY | -12.78% |
| 2023 Q3 | 30.34 Million USD | -33.94% |
| 2023 Q2 | 45.93 Million USD | 45.14% |
| 2023 Q1 | 31.65 Million USD | -41.11% |
| 2022 Q4 | 53.74 Million USD | 66.41% |
| 2022 FY | 755.07 Million CNY | -3.22% |
| 2022 Q2 | 52.61 Million USD | 0.0% |
| 2022 Q3 | 32.29 Million USD | -38.62% |
| 2021 Q4 | 66.04 Million USD | 0.0% |
| 2021 Q2 | 49.6 Million USD | 0.0% |
| 2021 FY | 780.2 Million CNY | 66.55% |
| 2020 Q4 | 38.07 Million USD | 0.0% |
| 2020 FY | 468.45 Million CNY | 130.18% |
| 2020 Q2 | 21.72 Million USD | 0.0% |
| 2019 FY | 203.51 Million CNY | 73.9% |
| 2019 Q4 | 16.97 Million USD | 0.0% |
| 2019 Q2 | 10.78 Million USD | 0.0% |
| 2018 FY | 117.03 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -911.495% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -17749.563% |
| SQZ Biotechnologies Company | 85.61 Million USD | -925.27% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -2870.345% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -2256.221% |
| Mesoblast Limited | 5.9 Million USD | -14773.365% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -58347.738% |
| Genus plc | 147.7 Million USD | -494.33% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -9898.891% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -65333.959% |
| Marizyme, Inc. | 19.23 Million USD | -4462.545% |
| ContraFect Corporation | 56.88 Million USD | -1443.051% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -10426.754% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -19811.347% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -59262.625% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -30001.346% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -31359.272% |
| MultiCell Technologies, Inc. | 567.42 USD | -154704704.201% |
| Accustem Sciences Inc. | 3.74 Million USD | -23331.068% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -921.381% |
| EV Biologics, Inc. | 531.96 Thousand USD | -164916.674% |
| Q BioMed Inc. | 3.43 Million USD | -25443.236% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -3451.794% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -225234.346% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -33308.892% |
| Biomind Labs Inc. | 994.18 Thousand USD | -88196.308% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | -289.295% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -12966.747% |
| Skye Bioscience, Inc. | 13.54 Million USD | -6379.592% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -42747.848% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 3511404.0% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -17310.122% |
| IMV Inc. | 37.7 Million USD | -2227.882% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -5382.904% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -47735.453% |
| GB Sciences, Inc. | 1.42 Million USD | -61696.581% |
| Alpha Cognition Inc. | 9.7 Million USD | -8944.53% |
| HST Global, Inc. | 140.9 Thousand USD | -622882.535% |
| CSL Limited | 3.44 Billion USD | 74.548% |
| Halberd Corporation | 74.84 Thousand USD | -1172805.588% |
| Enzolytics Inc. | 2.17 Million USD | -40176.356% |
| Resverlogix Corp. | 12.71 Million USD | -6805.491% |
| Affymax, Inc. | 39.38 Million USD | -2128.777% |
| SYBLEU INC | 160.87 Thousand USD | -545553.795% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -23945.37% |
| argenx SE | 1.53 Billion USD | 42.758% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -1428.249% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -83982.95% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -55481.297% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -25680.658% |
| AVAX Technologies, Inc. | 7.31 Million USD | -11908.13% |
| Zenith Capital Corp. | 8.94 Million USD | -9715.789% |
| Genscript Biotech Corporation | 825.34 Million USD | -6.359% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -5038795.586% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -35652.043% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -511725.035% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -783.746% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -49785.604% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | -44413.736% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -46984.323% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -7977.906% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -45598.54% |
| BioStem Technologies, Inc. | 22.97 Million USD | -3720.821% |
| ONE Bio Corp. | 6.44 Million USD | -13522.606% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -483590.663% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -65633.535% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -77935.221% |
| Agentix Corp. | 1.37 Million USD | -63892.868% |
| LadRx Corporation | 3.81 Million USD | -22929.227% |
| Cell Source, Inc. | 4.32 Million USD | -20194.931% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -211180.474% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -94953.221% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -94953.221% |
| NovAccess Global Inc. | 2.46 Million USD | -35486.18% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -36401.043% |
| Itoco Inc. | 919.14 Thousand USD | -95404.834% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -20611.191% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -78347.364% |
| Kadimastem Ltd | 2.41 Million USD | -36322.623% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -335298.852% |
| CytoDyn Inc. | 18.05 Million USD | -4761.147% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -3487626.966% |
| Mobile Lads Corp. | 554.54 Thousand USD | -158196.336% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -398770.4% |
| Qrons Inc. | 643.67 Thousand USD | -136276.785% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -61727.789% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -39266.531% |
| Rebus Holdings, Inc. | 664 Thousand USD | -132102.711% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -48229.92% |
| International Stem Cell Corporation | 5.27 Million USD | -16553.88% |
| Bioxytran, Inc. | 3.82 Million USD | -22878.854% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -1667439.227% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -4315025.596% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -2320.521% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -54153.77% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -119196.581% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -28116.843% |
| Neutra Corp. | 243.82 Thousand USD | -359928.874% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -4928.504% |
| PureTech Health plc | 144.59 Million USD | -507.085% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -4184.191% |
| IXICO plc | 4.7 Million USD | -18549.373% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -9878.697% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -645.512% |
| CSL Limited | 3.89 Billion USD | 77.451% |
| Cellectis S.A. | 97.32 Million USD | -802.0% |